Analytical Data
-
Gene name
CKAP5
- Application
-
Alternative Names
TOG; TOGp; ch-TOG; Colonic and hepatic tumor overexpressed gene protein
-
Species
Human
-
Source
E. coli
-
Tag
N-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q14008
-
Expression Region
Met1~Ala198
-
Molecular Weight
26kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CKAP5 (Cytoskeleton-associated protein 5) is a crucial protein that plays a significant role in various cellular processes, particularly in the organization and function of the cytoskeleton. Its involvement in cell division, migration, and signaling pathways has made it a subject of interest in cancer research and other diseases. Recent studies suggest that CKAP5 may act as a regulator of microtubule dynamics, influencing cellular architecture and stability. Given its potential implications in tumor progression and metastasis, researchers are investigating CKAP5's mechanisms of action and its interactions with other cytoskeletal components. The recombinant expression of CKAP5 provides a valuable tool for studying its biochemical properties and function in vitro. By producing purified CKAP5 protein, scientists can conduct assays to explore its role in microtubule assembly and stability, as well as its potential as a therapeutic target. Moreover, CKAP5's expression patterns in various tissues and under different physiological conditions are being analyzed to understand its regulatory functions better. This research is expected to contribute to the development of targeted therapies for diseases characterized by cytoskeletal dysregulation, including cancer. As such, CKAP5's study offers insights not only into basic cell biology but also into potential clinical applications, making it a promising candidate for further exploration in the fields of molecular biology and medical research.
